secwatch.observer — SEC 8-K summary
======================================

Issuer:     Innoviva, Inc. (INVA)
CIK:        0001080014
Form:       8-K
Filed at:   2024-04-30T23:59:59+00:00
Accession:  0001193125-24-123033
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Innoviva appoints Derek Small to Board of Directors
---------------------------------------------------

- Derek Small appointed effective April 29, 2024; independent director.
- Managing Director at Luson Bioventures; former CEO of Assembly Biosciences and Naurex.
- Receives initial RSU award of $125,000, prorated RSU of $18,750, and options for 833 shares.
- Annual cash retainer of $50,000; standard indemnification agreement with Innoviva.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1080014/000119312524123033/0001193125-24-123033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1080014/000119312524123033/d833151d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-123033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer